Ramsay Health Care Ltd RMSYF

Morningstar Rating
$36.62 +6.62 (22.05%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMSYF is trading at a LOCK|>!JTgf premium.
Price
$29.58
Fair Value
LOCK|.@nrnWc
Uncertainty
LOCK|&$@<
1-Star Price
LOCK|.G!>!wk?
5-Star Price
LOCK|.^D?@!%s
Economic Moat
LOCK|pg!@
Capital Allocation
—

Trading Information

Previous Close Price
$30.00
Day Range
$36.62–36.62
52-Week Range
$20.00–36.62
Bid/Ask
$34.95 / $41.24
Shares Outstanding
230.83M
Market Cap
$8.45B
Volume/Avg
400 / 218

Key Statistics

Price/Earnings (Normalized)
27.41
Price/Sales
0.57
Dividend Yield (Trailing)
2.15%
Dividend Yield (Forward)
2.31%
Dividend Payment Schedule
Mar, Sep
Total Yield
2.15%

Company Profile

Ramsay Health Care is Australia's largest private hospital operator by benefits and admissions. Its operations also span acute and mental health hospitals in the UK and a 53% stake in Paris-listed European healthcare operator Ramsay Santé. Having divested its Ramsay Sime Darby Asian joint venture in 2023, the company has scaled back its global ambitions in favor of capital discipline and its core Australian business. It now proposes to spin off its Ramsay Santé stake to shareholders in 2026. We estimate Australia would account for around 80% of pro forma group EBIT should the demerger complete, with its UK operations making up the remainder. Ramsay treats both privately insured and publicly funded patients across its markets.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Core
Total Number of Employees
88,000

Competitors

Valuation

Metric
RMSYF
SHL
THC
Price/Earnings (Normalized)
27.4114.1513.80
Price/Book Value
2.111.094.61
Price/Sales
0.570.841.03
Price/Cash Flow
7.406.465.42
Price/Earnings
RMSYF
SHL
THC

Financial Strength

Metric
RMSYF
SHL
THC
Quick Ratio
0.740.841.22
Current Ratio
0.910.991.41
Interest Coverage
0.834.985.71
Quick Ratio
RMSYF
SHL
THC

Profitability

Metric
RMSYF
SHL
THC
Return on Assets (Normalized)
1.68%3.74%5.60%
Return on Equity (Normalized)
7.52%7.39%39.08%
Return on Invested Capital (Normalized)
2.06%5.35%10.73%
Return on Assets
RMSYF
SHL
THC

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Genesis Healthcare Inc Class A
GENNQ
LOCK|wlLOCK|Yc—
HCA Healthcare Inc
HCA
LOCK|kkfC#f<LOCK|mm#%n$102B
Fresenius SE & Co KGaA ADR
FSNUY
—LOCK|PrphX$28B
Tenet Healthcare Corp
THC
LOCK|cg%^!$LOCK|B#^>f$22B
Encompass Health Corp
EHC
—LOCK|^GR>$12B
DaVita Inc
DVA
LOCK|d$!>yZLOCK|$>nK$12B
Fresenius Medical Care AG
FMCQF
—LOCK|pch!$11B
Fresenius Medical Care AG ADR
FMS
LOCK|n%??@xLOCK|tD^$r$11B
Universal Health Services Inc Class B
UHS
LOCK|pHYZzpLOCK|<vFj$11B
Ensign Group Inc
ENSG
—LOCK|&<#>$10B

Sponsor Center